Europe Swine Vaccines Market Size & Outlook, 2023-2030
Europe swine vaccines market, 2018-2030 (US$M)
Related Markets
Europe swine vaccines market highlights
- The Europe swine vaccines market generated a revenue of USD 471.4 million in 2023.
- The market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 471.4 million |
| Market revenue in 2030 | USD 652.4 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.5% of the global swine vaccines market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,145.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Swine Vaccines Market Scope
Swine Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe swine vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 38.86% in 2023. Horizon Databook has segmented the Europe swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing pork production in European countries is likely to fuel market growth during the forecast period. For instance, according to European Parliamentary Research Service (EPRS), there were 148 million pigs in European countries in 2018, representing the largest livestock category.
In comparison with other meat industries, pig meat industry contributes 8.5% of total EU-27 agricultural production. Furthermore, import and export permissions for contract producers or distributor enterprises, as well as low projected product costs, are expected to boost the swine vaccines market in Europe.
For instance, in 2016, the UK-based Crans wick Foods company launched a project in Punjab to establish a pork processing plant, which would act as a catalyst to accelerate the process of value addition in animal husbandry field and boost farm diversity, offering improved pork to consumers across the state.
Reasons to subscribe to Europe swine vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe swine vaccines market databook
-
Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe swine vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Europe swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe swine vaccines market size, by country, 2018-2030 (US$M)
Europe Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
